Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Phase 1 and 1/2a Clinical Trial Evaluating the Safety and Efficacy of an Autologous Muscle Stem Cell Therapy in the Treatment of Urinary Incontinence in Isolated Epispadias

NCT04729582 is registered in ClinicalTrials.gov with Simone Spuler, MD as lead sponsor.

NCT NCT04729582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04729582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Phase 1 and 1/2a Clinical Trial Evaluating the Safety and Efficacy of an Autologous Muscle Stem Cell Therapy in the Treatment of Urinary Incontinence in Isolated Epispadias
Lead sponsor
Simone Spuler, MD
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
June 30, 2024
Completion date
October 31, 2026
Enrollment
21 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

epispadias, male, urinary incontinence